Copyright Reports & Markets. All rights reserved.

Global NK Cell Cytotoxicity Assay Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of NK Cell Cytotoxicity Assay Service by Type
    • 1.3.1 Overview: Global NK Cell Cytotoxicity Assay Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global NK Cell Cytotoxicity Assay Service Consumption Value Market Share by Type in 2025
    • 1.3.3 LDH (Lactate Dehydrogenase) Release Method
    • 1.3.4 51Cr Release Method
    • 1.3.5 Flow Cytometry Detection
    • 1.3.6 Other
  • 1.4 Global NK Cell Cytotoxicity Assay Service Market by Application
    • 1.4.1 Overview: Global NK Cell Cytotoxicity Assay Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Cancer Research
    • 1.4.3 Infectious Disease Research
    • 1.4.4 Immunotherapy Development
  • 1.5 Global NK Cell Cytotoxicity Assay Service Market Size & Forecast
  • 1.6 Global NK Cell Cytotoxicity Assay Service Market Size and Forecast by Region
    • 1.6.1 Global NK Cell Cytotoxicity Assay Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global NK Cell Cytotoxicity Assay Service Market Size by Region, (2021-2032)
    • 1.6.3 North America NK Cell Cytotoxicity Assay Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe NK Cell Cytotoxicity Assay Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America NK Cell Cytotoxicity Assay Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Agilent
    • 2.1.1 Agilent Details
    • 2.1.2 Agilent Major Business
    • 2.1.3 Agilent NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.1.4 Agilent NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Agilent Recent Developments and Future Plans
  • 2.2 Laboratories
    • 2.2.1 Laboratories Details
    • 2.2.2 Laboratories Major Business
    • 2.2.3 Laboratories NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.2.4 Laboratories NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Laboratories Recent Developments and Future Plans
  • 2.3 Explicyte
    • 2.3.1 Explicyte Details
    • 2.3.2 Explicyte Major Business
    • 2.3.3 Explicyte NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.3.4 Explicyte NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Explicyte Recent Developments and Future Plans
  • 2.4 Reaction Biology
    • 2.4.1 Reaction Biology Details
    • 2.4.2 Reaction Biology Major Business
    • 2.4.3 Reaction Biology NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.4.4 Reaction Biology NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Reaction Biology Recent Developments and Future Plans
  • 2.5 Axion BioSystems
    • 2.5.1 Axion BioSystems Details
    • 2.5.2 Axion BioSystems Major Business
    • 2.5.3 Axion BioSystems NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.5.4 Axion BioSystems NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Axion BioSystems Recent Developments and Future Plans
  • 2.6 Sartorius
    • 2.6.1 Sartorius Details
    • 2.6.2 Sartorius Major Business
    • 2.6.3 Sartorius NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.6.4 Sartorius NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sartorius Recent Developments and Future Plans
  • 2.7 ICE Bioscience
    • 2.7.1 ICE Bioscience Details
    • 2.7.2 ICE Bioscience Major Business
    • 2.7.3 ICE Bioscience NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.7.4 ICE Bioscience NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ICE Bioscience Recent Developments and Future Plans
  • 2.8 Shanghai Saily Biotechnology
    • 2.8.1 Shanghai Saily Biotechnology Details
    • 2.8.2 Shanghai Saily Biotechnology Major Business
    • 2.8.3 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.8.4 Shanghai Saily Biotechnology NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Shanghai Saily Biotechnology Recent Developments and Future Plans
  • 2.9 ProBio
    • 2.9.1 ProBio Details
    • 2.9.2 ProBio Major Business
    • 2.9.3 ProBio NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.9.4 ProBio NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 ProBio Recent Developments and Future Plans
  • 2.10 Charles River
    • 2.10.1 Charles River Details
    • 2.10.2 Charles River Major Business
    • 2.10.3 Charles River NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.10.4 Charles River NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Charles River Recent Developments and Future Plans
  • 2.11 Imodels
    • 2.11.1 Imodels Details
    • 2.11.2 Imodels Major Business
    • 2.11.3 Imodels NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.11.4 Imodels NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Imodels Recent Developments and Future Plans
  • 2.12 Xeno Diagnostics
    • 2.12.1 Xeno Diagnostics Details
    • 2.12.2 Xeno Diagnostics Major Business
    • 2.12.3 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.12.4 Xeno Diagnostics NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Xeno Diagnostics Recent Developments and Future Plans
  • 2.13 Cyagen
    • 2.13.1 Cyagen Details
    • 2.13.2 Cyagen Major Business
    • 2.13.3 Cyagen NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.13.4 Cyagen NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Cyagen Recent Developments and Future Plans
  • 2.14 MarinBio
    • 2.14.1 MarinBio Details
    • 2.14.2 MarinBio Major Business
    • 2.14.3 MarinBio NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.14.4 MarinBio NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 MarinBio Recent Developments and Future Plans
  • 2.15 Pharmalegacy
    • 2.15.1 Pharmalegacy Details
    • 2.15.2 Pharmalegacy Major Business
    • 2.15.3 Pharmalegacy NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.15.4 Pharmalegacy NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Pharmalegacy Recent Developments and Future Plans
  • 2.16 Celentyx
    • 2.16.1 Celentyx Details
    • 2.16.2 Celentyx Major Business
    • 2.16.3 Celentyx NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.16.4 Celentyx NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Celentyx Recent Developments and Future Plans
  • 2.17 Crown Bioscience
    • 2.17.1 Crown Bioscience Details
    • 2.17.2 Crown Bioscience Major Business
    • 2.17.3 Crown Bioscience NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.17.4 Crown Bioscience NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Crown Bioscience Recent Developments and Future Plans
  • 2.18 Cellomatics Biosciences
    • 2.18.1 Cellomatics Biosciences Details
    • 2.18.2 Cellomatics Biosciences Major Business
    • 2.18.3 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Product and Solutions
    • 2.18.4 Cellomatics Biosciences NK Cell Cytotoxicity Assay Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Cellomatics Biosciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global NK Cell Cytotoxicity Assay Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of NK Cell Cytotoxicity Assay Service by Company Revenue
    • 3.2.2 Top 3 NK Cell Cytotoxicity Assay Service Players Market Share in 2025
    • 3.2.3 Top 6 NK Cell Cytotoxicity Assay Service Players Market Share in 2025
  • 3.3 NK Cell Cytotoxicity Assay Service Market: Overall Company Footprint Analysis
    • 3.3.1 NK Cell Cytotoxicity Assay Service Market: Region Footprint
    • 3.3.2 NK Cell Cytotoxicity Assay Service Market: Company Product Type Footprint
    • 3.3.3 NK Cell Cytotoxicity Assay Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global NK Cell Cytotoxicity Assay Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global NK Cell Cytotoxicity Assay Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global NK Cell Cytotoxicity Assay Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global NK Cell Cytotoxicity Assay Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America NK Cell Cytotoxicity Assay Service Consumption Value by Type (2021-2032)
  • 6.2 North America NK Cell Cytotoxicity Assay Service Market Size by Application (2021-2032)
  • 6.3 North America NK Cell Cytotoxicity Assay Service Market Size by Country
    • 6.3.1 North America NK Cell Cytotoxicity Assay Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe NK Cell Cytotoxicity Assay Service Consumption Value by Type (2021-2032)
  • 7.2 Europe NK Cell Cytotoxicity Assay Service Consumption Value by Application (2021-2032)
  • 7.3 Europe NK Cell Cytotoxicity Assay Service Market Size by Country
    • 7.3.1 Europe NK Cell Cytotoxicity Assay Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 7.3.3 France NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific NK Cell Cytotoxicity Assay Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific NK Cell Cytotoxicity Assay Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific NK Cell Cytotoxicity Assay Service Market Size by Region
    • 8.3.1 Asia-Pacific NK Cell Cytotoxicity Assay Service Consumption Value by Region (2021-2032)
    • 8.3.2 China NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 8.3.5 India NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America NK Cell Cytotoxicity Assay Service Consumption Value by Type (2021-2032)
  • 9.2 South America NK Cell Cytotoxicity Assay Service Consumption Value by Application (2021-2032)
  • 9.3 South America NK Cell Cytotoxicity Assay Service Market Size by Country
    • 9.3.1 South America NK Cell Cytotoxicity Assay Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa NK Cell Cytotoxicity Assay Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa NK Cell Cytotoxicity Assay Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa NK Cell Cytotoxicity Assay Service Market Size by Country
    • 10.3.1 Middle East & Africa NK Cell Cytotoxicity Assay Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE NK Cell Cytotoxicity Assay Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 NK Cell Cytotoxicity Assay Service Market Drivers
  • 11.2 NK Cell Cytotoxicity Assay Service Market Restraints
  • 11.3 NK Cell Cytotoxicity Assay Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 NK Cell Cytotoxicity Assay Service Industry Chain
  • 12.2 NK Cell Cytotoxicity Assay Service Upstream Analysis
  • 12.3 NK Cell Cytotoxicity Assay Service Midstream Analysis
  • 12.4 NK Cell Cytotoxicity Assay Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global NK Cell Cytotoxicity Assay Service market size was valued at US$ 320 million in 2025 and is forecast to a readjusted size of US$ 451 million by 2032 with a CAGR of 5.1% during review period.
    NK cell cytotoxicity assay service is a testing service designed to evaluate the functional activity of natural killer (NK) cells. It involves in vitro experiments to measure the cytotoxic effects of NK cells on target cells, such as tumor cells or virus-infected cells. This service is widely used in immunotherapy research, drug screening, and immune function assessment.
    This report is a detailed and comprehensive analysis for global NK Cell Cytotoxicity Assay Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global NK Cell Cytotoxicity Assay Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global NK Cell Cytotoxicity Assay Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global NK Cell Cytotoxicity Assay Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global NK Cell Cytotoxicity Assay Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for NK Cell Cytotoxicity Assay Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global NK Cell Cytotoxicity Assay Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agilent, Laboratories, Explicyte, Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology, ProBio, Charles River, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    NK Cell Cytotoxicity Assay Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    LDH (Lactate Dehydrogenase) Release Method
    51Cr Release Method
    Flow Cytometry Detection
    Other
    Market segment by Application
    Cancer Research
    Infectious Disease Research
    Immunotherapy Development
    Market segment by players, this report covers
    Agilent
    Laboratories
    Explicyte
    Reaction Biology
    Axion BioSystems
    Sartorius
    ICE Bioscience
    Shanghai Saily Biotechnology
    ProBio
    Charles River
    Imodels
    Xeno Diagnostics
    Cyagen
    MarinBio
    Pharmalegacy
    Celentyx
    Crown Bioscience
    Cellomatics Biosciences
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe NK Cell Cytotoxicity Assay Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of NK Cell Cytotoxicity Assay Service, with revenue, gross margin, and global market share of NK Cell Cytotoxicity Assay Service from 2021 to 2026.
    Chapter 3, the NK Cell Cytotoxicity Assay Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and NK Cell Cytotoxicity Assay Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of NK Cell Cytotoxicity Assay Service.
    Chapter 13, to describe NK Cell Cytotoxicity Assay Service research findings and conclusion.

    Buy now